Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the BD OneFlow Acute Leukemia Panel (BD OneFlow ALOT, BCP-ALL T1, and AML T1-T4) on the BD FACSLyric Flow Cytometer Using Leftover, De-identified Specimens

NCT05035615 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT05035615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05035615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the BD OneFlow Acute Leukemia Panel (BD OneFlow ALOT, BCP-ALL T1, and AML T1-T4) on the BD FACSLyric Flow Cytometer Using Leftover, De-identified Specimens
Lead sponsor
Becton, Dickinson and Company
Phase
Observational
Overall status
Completed
Start date
November 2, 2021
Completion date
July 18, 2024
Enrollment
332 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia